ASTH vs. MARA, QBTS, WSC, AMTM, LIF, RELY, GLOB, FTDR, STNE, and TNET
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include MARA (MARA), D-Wave Quantum (QBTS), WillScot Mobile Mini (WSC), Amentum (AMTM), Life360 (LIF), Remitly Global (RELY), Globant (GLOB), Frontdoor (FTDR), StoneCo (STNE), and TriNet Group (TNET). These companies are all part of the "business services" industry.
Astrana Health vs.
MARA (NASDAQ:MARA) and Astrana Health (NASDAQ:ASTH) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, community ranking, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.
44.5% of MARA shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 0.8% of MARA shares are owned by insiders. Comparatively, 20.0% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
MARA received 297 more outperform votes than Astrana Health when rated by MarketBeat users. However, 80.00% of users gave Astrana Health an outperform vote while only 53.78% of users gave MARA an outperform vote.
MARA presently has a consensus price target of $20.83, suggesting a potential upside of 26.34%. Astrana Health has a consensus price target of $53.29, suggesting a potential upside of 100.85%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than MARA.
In the previous week, MARA had 31 more articles in the media than Astrana Health. MarketBeat recorded 37 mentions for MARA and 6 mentions for Astrana Health. Astrana Health's average media sentiment score of 1.04 beat MARA's score of 0.52 indicating that Astrana Health is being referred to more favorably in the news media.
MARA has a beta of 6.61, meaning that its stock price is 561% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.
MARA has a net margin of 27.48% compared to Astrana Health's net margin of 3.63%. Astrana Health's return on equity of 9.37% beat MARA's return on equity.
MARA has higher earnings, but lower revenue than Astrana Health. MARA is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
Summary
Astrana Health beats MARA on 11 of the 18 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Astrana Health Competitors List
Related Companies and Tools
This page (NASDAQ:ASTH) was last updated on 6/11/2025 by MarketBeat.com Staff
